Holen Sie sich die Stockscreener-App
10.72
0.09%
0.010
Schlusskurs vom Vortag:
$10.71
Offen:
$10.72
24-Stunden-Volumen:
25,044
Relative Volume:
0.72
Marktkapitalisierung:
$260.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$6.66M
KGV:
54.09
EPS:
0.1982
Netto-Cashflow:
$-379.20K
1W Leistung:
+0.09%
1M Leistung:
+0.47%
6M Leistung:
+2.58%
1J Leistung:
+4.38%
1-Tages-Spanne:
$10.72
$10.72
1-Wochen-Bereich:
$10.72
$10.72
52-Wochen-Spanne:
$10.22
$10.72
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Firmenname
Drugs Made In America Acquisition Corp
Sektor
Branche
Telefon
646-726-7074
Adresse
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, CCXI, NBRG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.72 | 260.01M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
11.95 | 3.57B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.95 | 2.69B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
30.15 | 1.70B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
17.20 | 950.80M | 0 | 0 | 0 | 0.0647 |
NBRG
Newbridge Acquisition Ltd
|
10.02 | 805.59M | 0 | -13,300 | 0 | -0.0021 |
Drugs Made In America Acquisition Corp Aktie (DMAA) Neueste Nachrichten
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pfizer Inc. - Encyclopedia Britannica
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
Law firm launches legal inquiries into mergers of LXP, DMAA, PSNL, and FNWD for shareholder protection. - Pluang
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.040 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - tradingkey.com
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BLZR|Trailblazer Acquisition Corp|Price:10.160| - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
TradingKey - TradingKey
LATA|Galata Acquisition Corp II|Price:10.150|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.710| - TradingKey
WTG|Wintergreen Acquisition Corp|Price:10.490|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition II Corp. (DMII) Holds Steady at $10.09 Amid SPAC StabilityGap and Go - dars.gov.et
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) - PR Newswire
Drugs Made In America Acquisition Corp. (DMAA) Amends Merger Agreement With Power Analytics Global Corp – Key Details, Dates, and SEC Filing Information – Minichart - Minichart
Drugs Made In America (NASDAQ: DMAA) tightens PAGC merger terms and sponsor economics - Stock Titan
Drugs Made In America amends merger agreement terms - TipRanks
Drugs Made In America Acquisition Revises PAGC Merger; Sets $30M Target Cash and Founder Share Forfeiture - TradingView
Drugs Made In America Acquisition II Corp. Right (DMIIR): Trading Flat at $0.08 Amid Low ActivityFRAMA Signal - dars.gov.et
Finanzdaten der Drugs Made In America Acquisition Corp-Aktie (DMAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):